August 1, 2017 5:00pm

 

I thought there would have been more demand for the oversold

These summer months have shown below average performance as Q2 results come right in the middle of a seasonally unfavorable period

 

Am I a day early or a day late?

 

Pre-open indications: 2 hit and 4 miss

 

 

It’s called premium content for a reason … I define insight  from a real-time perspective discussing equity share pricing, attractiveness and support levels as stock pricing changes by the hour … if not the minute!

Others don’t even come close!

 

I answer one question, in which company should investors commit and keep their money.

 

 

 

Tuesday’s results have implications to Wednesday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

 

Henry’omics:

From the pre-open’s investor’s newsletter, “the good, the not so bad and the fugly - should our ranking system reflect new acronyms as Q2 financial results are kicking-in? The real question is how many “bottom huggers” are going to be looking for capital market access post releases. Are we alternating to the positive today, after three negative closes in the pocket?”

  • Short and near-term growth prospects are nowhere to be found!

As I had stated, the technical backdrop for stocks shows investors should be cautious as volume was still LOW but rising as the sector slipped yet again; which seems higher in selling – again; it is a gauge of negative sentiment and investor non-interest.

  • The cell therapy sector is entering the usual weak seasonal period side-by-side with investor pessimistic views of quarterly financial results.

Historically, the period from August through October has seen stocks struggle and a period when corrections have tended to occur more than often,

 

The jury is still out even with quarterly reporting …

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The first hour was negative with an A/DL of 8/32 and 3 flats;

·         The mid-day was negative with an A/DL of 6/34 and 3 flats;

·         The close was negative  with an A/DL of 8/31 and 4 flats;

 

 

Pre-open indications:  2 hit and 4 miss

  • Capricor (CAPR) closed up +$0.03 – miss;
  • Cellectis SA (CLLS) closed down $0.55 – miss;
  • Cesca Therapeutics (KOOL) closed down -$0.05 – hit;
  • Kite Pharma (KITE) closed down -$0.43 – miss;
  • Organovo (ONVO) closed down - $0.18 – miss;
  • Neuralstem (CUR) closed down -$0.07 – hit;

 

 

Daily analytics:

U.S. stock-market indexes closed modestly higher on Tuesday with the Dow closing at a record, just 37 points below the psychologically important 22,000 level.

The NASDAQ advanced 14.82 points, or 0.2%, to 6,362.94.

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded at 10.09 down -1.66% …

  • Monday traded 10.30 up +0.10% after Friday closed at 10.29 up +1.78, Thursday’s +5.31% to 10.11, Wednesday’s 9.60 and last Tuesday’s near 9.43 …

 

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Tuesday was up +0.20%

·         Monday down -0.31%

·         Friday down -0.28%

·         Thursday was down -0.64%

·         Wednesday was down -0.57%

·         Last Tuesday was up +0.89%

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Tuesday was down -1.04%

·         Monday down -0.85%

·         Friday up +0.63%

·         Thursday was down -1.87%

·         Wednesday was up +0.65%

·         Last Tuesday was down -1.08%

 

 

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %’s migrate…

·         Tuesday’s decliners ranged from -0.14% <MESO> to -8.51% <CYTX> in 31 equities;

·         Monday’s decliners ranged from -0.03% <IMUC> to -8.16% <FCSC> in 31 equities;

·         Friday’s decliners ranged from -0.02% <CYTX> to -12,31% <CAPR> in 25 equities;

·         Thursday’s decliners ranged from -0.45% <OPXA> to -29.15% <CUR> in 31 equities;

·         Wednesday’s decliners ranged from -0.30% <XON> to -12.10% <CUR> in 18 equities;

·         Last Tuesday’s decliners ranged from -0.10% <JUNO> to -49.64% <CUR> in 29 equities;

Versus

………… look at the percentage’s (%) and their decreases …….

·         Tuesday’s gainers ranged from +0.87%  <BLFS> to +5.08% <FCSC> in 8 equities;

·         Monday’s gainers ranged from +0.49%  <VTGN> to +4.64% <AXGN> in 9 equities;

·         Friday’s gainers ranged from +0.27%  <XON> to +11.92% <KOOL> in 16 equities;

·         Thursday’s gainers ranged from +0.28%  <FCSC> to +28.71% <CAPR> in 10 equities;

·         Wednesday’s gainers ranged from +0.28%  <VSTM> to +18.85% <ISCO> in 21 equities;

·         Last Tuesday’s gainers ranged from +0.56%  <XON> to +2.16% <NWBO> in 10 equities;

 

 

Some of MY working trend lines or indications:

… The greatest volume to the downside:  SGMO, CYTX, JUNO, ONVO and IMUC

… Upside volume was weighted to:  VSTM, CAPR, AST, RGNX and FCSC

… Biggest $ downside:  BLUE, ONCE, CLLS, KITE and QURE

… Largest $ upside:  RGNX, FCSC, VSTM, CAPR and BLFS

… Flat: ATHX, MDXG and RENE.L

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.